M. A. Boogaerts

1.6k total citations
29 papers, 1.2k citations indexed

About

M. A. Boogaerts is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, M. A. Boogaerts has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 9 papers in Genetics and 6 papers in Oncology. Recurrent topics in M. A. Boogaerts's work include Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Hematological disorders and diagnostics (4 papers). M. A. Boogaerts is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Hematological disorders and diagnostics (4 papers). M. A. Boogaerts collaborates with scholars based in Belgium, United States and Switzerland. M. A. Boogaerts's co-authors include Guido Tricot, G. Verhoef, Harry S. Jacob, Pierre Zachée, Willy Goossens, Charles F. Moldow, Osamu Yamada, Jan Ceuppens, J. Van Damme and H Demuynck and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer.

In The Last Decade

M. A. Boogaerts

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. A. Boogaerts Belgium 20 823 266 262 242 232 29 1.2k
C. G. Geary United Kingdom 20 856 1.0× 185 0.7× 439 1.7× 149 0.6× 149 0.6× 62 1.2k
S Kariyone Japan 13 672 0.8× 177 0.7× 243 0.9× 230 1.0× 300 1.3× 62 1.1k
Emmanuel C. Besa United States 23 1.0k 1.2× 425 1.6× 693 2.6× 167 0.7× 481 2.1× 68 1.7k
H. Heimpel Germany 15 706 0.9× 113 0.4× 295 1.1× 174 0.7× 326 1.4× 38 1.1k
N Jamal Canada 17 607 0.7× 218 0.8× 237 0.9× 210 0.9× 358 1.5× 35 1.3k
Robert Hast Sweden 23 1.4k 1.7× 461 1.7× 587 2.2× 345 1.4× 317 1.4× 99 2.0k
Pietro Pioltelli Italy 23 969 1.2× 195 0.7× 778 3.0× 319 1.3× 213 0.9× 80 2.0k
Nada Suvajdžić Serbia 16 649 0.8× 293 1.1× 215 0.8× 135 0.6× 91 0.4× 127 1.0k
Susan McKenzie United States 14 766 0.9× 367 1.4× 247 0.9× 342 1.4× 120 0.5× 19 1.2k
Athanasios Zomas Greece 18 852 1.0× 502 1.9× 366 1.4× 443 1.8× 207 0.9× 55 1.3k

Countries citing papers authored by M. A. Boogaerts

Since Specialization
Citations

This map shows the geographic impact of M. A. Boogaerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. Boogaerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. Boogaerts more than expected).

Fields of papers citing papers by M. A. Boogaerts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. A. Boogaerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. Boogaerts. The network helps show where M. A. Boogaerts may publish in the future.

Co-authorship network of co-authors of M. A. Boogaerts

This figure shows the co-authorship network connecting the top 25 collaborators of M. A. Boogaerts. A scholar is included among the top collaborators of M. A. Boogaerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. Boogaerts. M. A. Boogaerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Russell, NH, Rolf M. Mesters, J. Schubert, et al.. (2008). A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy. Haematologica. 93(3). 405–412. 51 indexed citations
2.
Schoemans, Hélène, Koen Theunissen, Johan Maertens, et al.. (2006). Adult umbilical cord blood transplantation: a comprehensive review. Bone Marrow Transplantation. 38(2). 83–93. 84 indexed citations
3.
Larson, Richard A., M. A. Boogaerts, Elihu H. Estey, et al.. (2002). Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin). Leukemia. 16(9). 1627–1636. 168 indexed citations
4.
Peetermans, Willy, et al.. (2001). Autoimmune haemolytic anaemia triggered by Bartonella henselae infection: a case report. British Journal of Haematology. 115(4). 924–925. 23 indexed citations
5.
Maes, Brigitte, Mira Meeus, Lucienne Michaux, et al.. (1999). Application of the International Prognostic Scoring System for myelodysplastic syndromes. Annals of Oncology. 10(7). 825–830. 27 indexed citations
6.
Demuynck, H, et al.. (1995). Risks of rhG-CSF treatment in drug-induced agranulocytosis. Annals of Hematology. 70(3). 143–147. 3 indexed citations
7.
Zachée, Pierre, et al.. (1995). Reduced Glutathione for the Treatment of Anemia during Hemodialysis: A Preliminary Communication. ˜The œNephron journals/Nephron journals. 71(3). 343–349. 17 indexed citations
8.
Demuynck, H, Michel Delforge, Pierre Zachée, et al.. (1995). An update on peripheral blood progenitor cell transplantation. Annals of Hematology. 71(1). 29–33. 8 indexed citations
9.
Verhoef, G., Stefania Pittaluga, Chris De Wolf‐Peeters, & M. A. Boogaerts. (1995). FAB classification of myelodysplastic syndromes: merits and controversies. Annals of Hematology. 71(1). 3–11. 30 indexed citations
10.
11.
Casteele, Marc Van de, G. Verhoef, H Demuynck, Pierre Zachée, & M. A. Boogaerts. (1994). Hypercalcemia, monoclonal protein, and osteolytic bone lesions in chronic lymphocytic leukemia. Annals of Hematology. 69(2). 79–80. 12 indexed citations
12.
Zachée, Pierre, et al.. (1994). Neutrophil Adhesion Molecules in Chronic Hemodialysis Patients. ˜The œNephron journals/Nephron journals. 68(2). 192–196. 12 indexed citations
13.
Zachée, Pierre, et al.. (1993). Chronic renal failure due to renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria.. PubMed. 39(1). 28–31. 21 indexed citations
14.
Zachée, Pierre, Augustin Ferrant, R. Daelemans, et al.. (1993). Oxidative Injury to Erythrocytes, Cell Rigidity and Splenic Hemolysis in Hemodialyzed Patients before and during Erythropoietin Treatment. ˜The œNephron journals/Nephron journals. 65(2). 288–293. 37 indexed citations
15.
Verhoef, Gregor, Peter Meeus, Michel Stul, et al.. (1992). Cytogenetic and molecular studies of the Philadelphia translocation in myelodysplastic syndromes. Cancer Genetics and Cytogenetics. 59(2). 161–166. 25 indexed citations
16.
Verhoef, G., Pierre Zachée, Augustin Ferrant, et al.. (1992). Recombinant human erythropoietin for the treatment of anemia in the myelodysplastic syndromes: A clinical and erythrokinetic assessment. Annals of Hematology. 64(1). 16–21. 42 indexed citations
17.
Verhoef, Gregor, et al.. (1991). Chronic myelogenous leukemia after treatment with 131I for thyroid carcinoma. Cancer Genetics and Cytogenetics. 55(2). 217–224. 19 indexed citations
18.
Keyser, Filip De, et al.. (1990). Pyoderma Gangrenosum in a Patient with Chronic Myeloid Leukemia. Acta Clinica Belgica. 45(5). 340–342. 4 indexed citations
19.
Tricot, Guido, M. A. Boogaerts, Robert Vlietinck, Marie‐Paule Emonds, & R. L. Verwilghen. (1987). The role of intensive remission induction and consolidation therapy in patients with acute myeloid leukaemia. British Journal of Haematology. 66(1). 37–44. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. G. Geary Breakdown of academic impact, for papers by S Kariyone Breakdown of academic impact, for papers by Emmanuel C. Besa Breakdown of academic impact, for papers by H. Heimpel Breakdown of academic impact, for papers by N Jamal Breakdown of academic impact, for papers by Robert Hast Breakdown of academic impact, for papers by Pietro Pioltelli Breakdown of academic impact, for papers by Nada Suvajdžić Breakdown of academic impact, for papers by Susan McKenzie Breakdown of academic impact, for papers by Athanasios Zomas
Rankless by CCL
2026